Biotechnology companies apply biological science to develop products, services and technologies that address challenges in healthcare, agriculture, industry and environmental sustainability.
This category includes companies working on:
Browse 463 UK biotechnology companies below.
Antibody therapy to deplete amyloid deposits in ATTR cardiomyopathy
Immutrin is a biotechnology company developing an engineered antibody therapeutic designed to actively remove amyloid deposits from tissues in patients with amyloidosis. Its lead…
AI-driven enzyme engineering platform for pharmaceutical manufacturing
Imperagen is a biotechnology company developing an automated enzyme engineering platform that combines AI-powered protein design with synthetic biology and laboratory automation.…
Pre-cancer intervention to prevent cancer before it develops
Omos Biosciences is an early-stage biotechnology company developing approaches to cancer prevention through intervention at the pre-cancerous stage, rather than treatment of…
Phage-based blood test for tuberculosis and mycobacterial disease
PBD Biotech is a diagnostics company that develops phage-based blood and milk tests for detecting active mycobacterial infections, including bovine tuberculosis, Johne's disease…
Synthetic plant metabolites for osteoarthritis and age-related disease
AKL Therapeutics is a privately held UK pharmaceutical company developing APPA, a patented oral investigational medicine combining two synthetic plant metabolites that act…
Electrospun biomimetic scaffold platform for wound repair
Corryn Biotechnologies is a Welsh biotechnology company developing an electrospinning platform that fabricates nano- and microfibrous polymer scaffolds directly onto wound sites…
In vivo cell reprogramming therapies for degenerative disease
Mogrify is a biotechnology company developing a novel class of in vivo reprogramming therapies for degenerative diseases. Its proprietary platforms use large-scale transcriptomic…
Autophagy-enhancing small molecule drugs for neurodegeneration and rare disease
Samsara Therapeutics is a drug discovery company developing first-in-class small molecule therapeutics that restore autophagy, the cellular process of degrading and recycling…
Cell-free DNA capture reagents for liquid biopsy and cancer diagnostics
BIOCAPTIVA is a biotechnology company developing novel cell-free DNA capture technology to improve liquid biopsy for cancer research and diagnostics. Its proprietary polymer…
Next-generation targeted protein degradation therapeutics
Amphista Therapeutics is a Cambridge-based biopharmaceutical company developing next-generation targeted protein degradation medicines. Its proprietary platform generates…
Plant-based molecular farming platform for bio-identical collagen production
LeafyColl is a biotech developing a molecular farming platform for the scalable, plant-based production of bio-identical human collagen and other specialty proteins. The system…
Asymmetric biomaterial skin substitutes for acute and chronic wounds
Janus Biosciences is a biotech developing novel biomaterial skin substitutes for the treatment of acute and chronic wounds. The platform is based on asymmetric Janus material…